<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2021.772401</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Total Flavonoids of Chuju Decrease Oxidative Stress and Cell Apoptosis in Ischemic Stroke Rats: Network and Experimental Analyses</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Cong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1470844/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname> <given-names>Hao</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jiang</surname> <given-names>Hui-hui</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mao</surname> <given-names>Bin-bin</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yu</surname> <given-names>Hao</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>College of Life and Health Sciences, Anhui Science and Technology University</institution>, <addr-line>Chuzhou</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Pharmacy, Anhui University of Chinese Medicine</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>School of Chinese Medicine, Bozhou University</institution>, <addr-line>Bozhou</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Pharmacy, College of Life and Health Sciences, Anhui Science and Technology University</institution>, <addr-line>Chuzhou</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jacob Raber, Oregon Health &#x0026; Science University, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Stefania Schiavone, University of Foggia, Italy; Karla Hernandez-Fonseca, National Institute of Psychiatry Ramon de la Fuente Mu&#x00F1;iz (INPRFM), Mexico</p></fn>
<corresp id="c001">&#x002A;Correspondence: Hao Yu, <email>yhz_1230@163.com</email></corresp>
<fn fn-type="other" id="fn004"><p>This article was submitted to Neuropharmacology, a section of the journal Frontiers in Neuroscience</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>15</volume>
<elocation-id>772401</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2021 Wang, Chen, Jiang, Mao and Yu.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Wang, Chen, Jiang, Mao and Yu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p><bold>Background:</bold> Pharmacological research results showed that total flavonoids of Chuju (TFCJ) could be used to treat acute myocardial ischemia and myocardial ischemia-reperfusion injury. In this study, we explored the protective effect of TFCJ on ischemic stroke (IS) in the IS rat model. We hypothesized that TFCJ might exert its neuroprotective effects by suppressing apoptosis and oxidative stress that are closely related to PI3K/Akt/mTOR signaling pathway.</p>
<p><bold>Method:</bold> TFCJ (10, 20, and 40 mg/kg) was administered for 7 days. Rats (260 &#x00B1; 20 g) were subjected to middle cerebral artery occlusion (MCAO) for 2 h and reperfusion for 24 h. The neuroprotective effect of TFCJ was substantiated in terms of neurological deficits, oxidative stress (superoxide dismutase, glutathione peroxidase, catalase, and malondialdehyde), pathomorphological changes (HE staining and TUNEL staining), and neurobehavioral functions in the rats. Then, we employed network pharmacology to reveal the potential mechanism of TFCJ against IS. Western blot was used to determine the levels of PI3K/AKT/mTOR pathway proteins. The expression of BCL-2, BAX, and cleaved-Caspase-3 was also measured by Western blots and RT-PCR.</p>
<p><bold>Results:</bold> The histopathological assessment showed that TFCJ reduced MCAO-induced brain damage. Besides, TFCJ exerted a protective role in MCAO rats by alleviating cell apoptosis and oxidative stress. Network pharmacology showed that TFCJ might be used against IS through the PI3K/AKT signaling pathway. TFCJ reduced cell apoptosis and oxidative stress by increasing the level of p-AKT and p-mTOR in MCAO rats, while the effect of TFCJ was significantly reversed when applying LY294002 (PI3k inhibitor).</p>
<p><bold>Conclusion:</bold> These results indicated that TFCJ might decrease oxidative stress and apoptosis that are closely related to PI3K/Akt/mTOR pathway in IS. TFCJ is a promising authentic traditional Chinese medicine for the management of IS.</p>
</abstract>
<kwd-group>
<kwd>total flavonoids of Chuju</kwd>
<kwd>network pharmacology</kwd>
<kwd>ischemic stroke</kwd>
<kwd>MCAO</kwd>
<kwd>oxidative stress</kwd>
<kwd>apoptosis</kwd>
<kwd>PI3K/Akt/mTOR</kwd>
</kwd-group>
<contract-num rid="cn001">GXXT-2019-043</contract-num>
<contract-sponsor id="cn001">Collaborative Innovation Project of Colleges and Universities of Anhui Province<named-content content-type="fundref-id">10.13039/501100017679</named-content></contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="74"/>
<page-count count="14"/>
<word-count count="8206"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Stroke is a common disease characterized by a decreased or blockage in the brain&#x2019;s blood supply, which accounted for 11.59% of all deaths in 2019 (<xref ref-type="bibr" rid="B13">GBD 2019 Demographics Collaborators, 2020</xref>). In the United States, every year more than 795,000 people suffer a stroke, 610,000 of these being first or new cases (GBD 2019 Demographics Collaborators, 2020). Stroke can be categorized into ischaemic stroke (IS), cerebral hemorrhage, and subarachnoid hemorrhage (<xref ref-type="bibr" rid="B12">Garbuzova-Davis et al., 2016</xref>). In the United States, about 87% of all strokes are ischemic strokes (GBD 2019 Demographics Collaborators, 2020). IS mainly occurs due to the middle cerebral artery occlusion (MCAO), causing regional ischemia and hypoxia in brain tissue, leading to DNA damage and cell apoptosis (<xref ref-type="bibr" rid="B21">Li et al., 2018</xref>). Currently, there are no specific drugs for the clinical treatment of IS. While existing drugs can protect against free radical damage, thrombolytic drugs, antiplatelet aggregation drugs, anti-inflammatory drugs, and anticoagulants (<xref ref-type="bibr" rid="B6">Carvalhal et al., 2019</xref>; <xref ref-type="bibr" rid="B18">Kanazawa et al., 2019</xref>; <xref ref-type="bibr" rid="B27">Liu et al., 2019</xref>), they have also been associated with serious side effects and have a single mechanism of action (<xref ref-type="bibr" rid="B2">Allegaert et al., 2010</xref>; <xref ref-type="bibr" rid="B32">Ma et al., 2016</xref>; <xref ref-type="bibr" rid="B43">Polderman et al., 2018</xref>), which limits their clinical application (<xref ref-type="bibr" rid="B46">Ren et al., 2017</xref>).</p>
<p>Traditional Chinese medicines and their derived compounds have been increasingly used to treat ischemic cerebrovascular diseases. For instance, Xuesaitong (<xref ref-type="bibr" rid="B49">Shi et al., 2017</xref>; <xref ref-type="bibr" rid="B62">Yang et al., 2018</xref>), as a positive drug, is a commonly used drug for cerebrovascular diseases in clinic. Having multi-component, multi-pathway, and multi-target impact (<xref ref-type="bibr" rid="B11">Gao et al., 2015</xref>; <xref ref-type="bibr" rid="B74">Zhu et al., 2021</xref>), these medicines can provide new alternative strategies for the treatment of IS in China. Chuju is an authentic medicinal material produced in China, whose main active ingredients are total flavonoids of Chuju (TFCJ). TFCJ has been reported to have anti-myocardial ischemia (<xref ref-type="bibr" rid="B37">Nian et al., 2019</xref>), hypoglycemic (<xref ref-type="bibr" rid="B66">Yu et al., 2014</xref>), analgesic (<xref ref-type="bibr" rid="B67">Zhang, 2013</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B35">Miao et al., 2012</xref>), anti-blood stasis (<xref ref-type="bibr" rid="B64">Yu et al., 2012a</xref>), and anti-oxidant pharmacological properties (<xref ref-type="bibr" rid="B65">Yu et al., 2012b</xref>). Pharmacological research results showed that TFCJ could resist acute myocardial ischemia and myocardial ischemiareperfusion injury, and the mechanism might be associated with anti-lipid peroxidation and inhibition of intracellular Ca<sup>2 +</sup>overload (<xref ref-type="bibr" rid="B65">Yu et al., 2012b</xref>).</p>
<p>There are few studies on the pharmacological effects of TFCJ, while the protective effects of TFCJ against apoptosis and oxidative stress in cerebral ischemia-reperfusion injury have not yet been reported. <xref ref-type="bibr" rid="B5">Bu et al. (2019)</xref> reported that acacetin, 5,7-dihydroxy-4&#x2032;-methoxyflavone associated with inhibition of microglia-mediated inflammation and the NLRP3 signaling pathway, downregulates the protein expression of Toll-like receptor 4, nuclear factor kappa B, NLRP3, procaspase-1, caspase-1, pro-interleukin-1&#x03B2;, and interleukin-1&#x03B2; in the MCAO mice. Moreover, <xref ref-type="bibr" rid="B40">Pang et al. (2018)</xref> reported that apigenin, a low-toxicity and non-mutagenic flavone subclass of flavonoid, affects caveolin-1, VEGF, Bcl-2, cleaved-Caspase-3, Beclin-1, and mTOR expression, and promotes cell proliferation <italic>in vivo</italic> and <italic>in vitro</italic>, tube formation, and cell migration while inhibiting apoptosis and autophagy. In addition, <xref ref-type="bibr" rid="B28">Liu S. et al. (2020)</xref> reported that luteolin (3,4,5,7-tetrahydroxyflavone) upregulates SIRT3-targeted and p-mTOR expression, and downregulates p-AMPK expression <italic>in vivo</italic>. Also, <xref ref-type="bibr" rid="B57">Wang Y. Y. et al. (2020)</xref> reported that quercetin, a flavonoid present in many fruits and vegetables, could upregulate p-ERK and p-Akt expression <italic>in vivo</italic> and <italic>in vitro</italic>, which may have an important role against IS.</p>
<p>The MCAO involves two processes of ischemia and reperfusion, and the effects of the processes on the body at different periods are also different. In the early stage of reperfusion, the accumulation of free radicals, the cascade of reactions, and the calcium overload in nerve cells are the main causes of cerebral ischemic injury (<xref ref-type="bibr" rid="B38">Nishimura et al., 2016</xref>; <xref ref-type="bibr" rid="B9">Di Costanzo et al., 2020</xref>). Oxidative stress is the main reason for the aggravation of brain injury (<xref ref-type="bibr" rid="B8">Cornelius et al., 2013</xref>; <xref ref-type="bibr" rid="B55">Wang H. et al., 2020</xref>). After ischemia-reperfusion, the production of reactive oxygen species in cells is rapidly induced, leading to an imbalance in the ratio of oxidative factors and antioxidant factors in the brain.</p>
<p>PI3K/Akt/mTOR pathway is a core pathway involved in the occurrence and development of IS that has a regulatory effect on oxidative stress and apoptosis (<xref ref-type="bibr" rid="B4">Asati et al., 2016</xref>; <xref ref-type="bibr" rid="B34">Maiti et al., 2019</xref>). PI3K/Akt/mTOR signaling pathway is an important intracellular signal pathway (<xref ref-type="bibr" rid="B7">Chen et al., 2020</xref>) and one of the key signal pathways for neuroprotection. It is mainly involved in neuron proliferation, differentiation, cell metabolism, programmed apoptosis, and oxidative damage. As an intracellular phosphatidylinositol kinase (<xref ref-type="bibr" rid="B7">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="B45">Qiao et al., 2021</xref>), PI3K regulates the activation or inhibition of downstream pathways in IS to inhibit apoptosis and oxidative stress. As one of the key downstream pathways (<xref ref-type="bibr" rid="B7">Chen et al., 2020</xref>; Wang et al), AKT also has an important role in cell survival and apoptosis. Downstream targets, threonine (Thr308), and serine (Ser473) sites on Akt protein are phosphorylated and activated to activate downstream mTOR (<xref ref-type="bibr" rid="B68">Zhang G. et al., 2020</xref>). Increased mTOR activity can reduce autophagy and restore the complete complement of lysosomes in cells (<xref ref-type="bibr" rid="B72">Zhang T. et al., 2020</xref>). Therefore, the activation of PI3K/Akt/mTOR can promote neuroprotection after central nervous system injury, thus promoting the recovery of the central nervous system by maintaining nerve metabolism. The phosphorylation of Akt and mTOR has a cytoprotective role in cell protection through PI3K/Akt/mTOR signaling pathway (<xref ref-type="bibr" rid="B36">Miao et al., 2020</xref>; <xref ref-type="bibr" rid="B72">Zhang T. et al., 2020</xref>). Many studies have demonstrated the critical role of the PI3K/Akt/mTOR signal pathway in alleviating cerebral ischemic injury (<xref ref-type="bibr" rid="B52">Tian et al., 2019</xref>; <xref ref-type="bibr" rid="B69">Zhang H. et al., 2020</xref>). However, the role of the PI3KAkt-mTOR signal pathway in TFCJ&#x2019;s neuroprotection against IS has been rarely explored.</p>
<p>In this study, we explored the protective effect of TFCJ on IS in rats. We hypothesized that TFCJ might exert its neuroprotective effects by suppressing apoptosis and oxidative stress via activation of the PI3K/Akt/mTOR signaling pathway.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>Drugs</title>
<p>Air-dried TFCJ was treated twice with 70% aqueous ethanol (1:25, w/v), mixed and sonicated 60&#x00B0;C for 40 min, then concentrated in a rotary evaporato as described by the previous method (<xref ref-type="bibr" rid="B28">Liu S. et al., 2020</xref>; <xref ref-type="bibr" rid="B33">Ma et al., 2021</xref>). The crude extract was purified by the D-101 macroporous resin. TFCJ (60.21% content) was measured by UV-vis-spectrophotometer, and rutin was used as a reference compound. TFCJ and Xuesaitong (5 mg/pill, KPC Xuesaitong Pharmaceutical Co., Ltd.) were dissolved in 0.5% Carboxymethylcellulose sodium (CMC) before use.</p>
</sec>
<sec id="S2.SS2">
<title>Animals</title>
<p>Experiments were conducted on 7-weeks old-male Sprague-Dawley rats (240&#x2013;280 g body weight). All the animals were purchased from Huaxing Experimental Animal Farm (Zhengzhou, China), and maintained in standard housing conditions in colony cages 12 h light/dark cycles with free access to food and water. The animal care and experimental procedures were approved by Animal Ethics Committee of Anhui Science and Technology University. Because estrogen has a certain effect on the experimental results, male rats were selected as experimental animals.</p>
</sec>
<sec id="S2.SS3">
<title>Middle Cerebral Artery Occlusion Establishment</title>
<p>Before the operation, the rats were fasted for 12 h to reduce the mortality during and after the operation and anesthetized by intraperitoneal injection of 2% pentobarbital sodium (4 mL&#x22C5;kg<sup>&#x2013;1</sup>). We slowly inserted the threaded plug from the left external carotid artery (ECA) through the common carotid artery (CCA) into the internal carotid artery (ICA) until the origin of middle cerebral artery (MCA) was blocked as the previous literature (<xref ref-type="bibr" rid="B30">Longa et al., 1989</xref>; <xref ref-type="bibr" rid="B39">Olga Nikolaevna et al., 2020</xref>). After ischemia 2 h, the blood supply was restored, and reperfusion was achieved. The reperfusion process continued for 24 h.</p>
</sec>
<sec id="S2.SS4">
<title>Animal Grouping</title>
<sec id="S2.SS4.SSS1">
<title>Relationship Between Total Flavonoids of Chuju Anti-IS and Apoptosis and Oxidative Stress</title>
<p>To understand the relationship between TFCJ anti-IS and apoptosis and oxidative stress, 120 rats were randomly divided into six groups (<italic>n</italic> = 20/group). Sham group, MCAO group, TFCJ-H group (40 mg&#x22C5;kg<sup>&#x2013;1</sup> TFCJ), TFCJ-M group (20 mg&#x22C5;kg<sup>&#x2013;1</sup> TFCJ), TFCJ-L group (10 mg&#x22C5;kg<sup>&#x2013;1</sup> TFCJ), Xuesaitong group (40 mg&#x22C5;kg<sup>&#x2013;1</sup> Xuesaitong, equivalent dose conversion according to the body surface area of rats and humans).</p>
</sec>
<sec id="S2.SS4.SSS2">
<title>Relationship Between Total Flavonoids of Chuju Anti-IS and PI3K/Akt/mTOR Pathway</title>
<p>To explore the relationship between TFCJ anti-IS and PI3K/Akt/mTOR pathway, 40 rats were randomly divided into four groups (<italic>n</italic> = 10/group) as follows:Sham group, MCAO group, TFCJ group (40 mg&#x22C5;kg<sup>&#x2013;1</sup> TFCJ), TFCJ + LY group (40 mg&#x22C5;kg<sup>&#x2013;1</sup> TFCJ, 300 &#x03BC;g&#x22C5;kg<sup>&#x2013;1</sup> LY294002 injection in the tail vein before reperfusion 30 min).</p>
<p>All rats received intragastric administration once daily for 7 days before MCAO, MCAO group and sham group received 10 mL&#x22C5;kg<sup>&#x2013;1</sup> 0.5% CMC. Sham-operated rats received all surgical procedures but without the suture insertion.</p>
</sec>
</sec>
<sec id="S2.SS5">
<title>Neurological Evaluation</title>
<p>After reperfusion for 24 h, the degree of neurological injury was performed by researchers who were blinded to the grouping (<xref ref-type="bibr" rid="B17">Joya et al., 2021</xref>). Evaluations were performed as follows: Grade I, no nerve injury symptoms; Grade II, unable to fully extend the left front paw; Grade III, unable to fully extend the left front paw, circle to the left when walking; Grade IV, unable to fully extend the left front paw, hemiplegia to the left when walking; Grade V, loss of consciousness, unable to walk spontaneously.</p>
</sec>
<sec id="S2.SS6">
<title>Cerebral Infarct Area</title>
<p>After neurological evaluation, the rats were sacrificed, and the rat brain was sliced with 2 mm thin slices along the coronal plane. The slices were incubated with 2% TTC dye solution at 37&#x00B0;C for 15 min in dark. After rinsing, the slices were fixed in 4% paraformaldehyde over 24 h. Image pro plus 6.0 software (Media Cybernetics, Rockville, MD, United States) was employed for infarct area analysis. Red stained areas corresponded to unaffected areas, while that stained in white was the infarcted area (<xref ref-type="bibr" rid="B17">Joya et al., 2021</xref>). The cerebral infarct area percentage was: (cerebral infarct area/total brain area) &#x00D7; 100%, which is the percentage of the brain area affected by the infarct.</p>
</sec>
<sec id="S2.SS7">
<title>Oxidative Stress Evaluation</title>
<p>The brain hemisphere ipsilateral to MCAO was homogenized with pre-cooled physiological salt, centrifuged like the blood, and the supernatant was immediately collected and stored in the refrigerator at &#x2212;80&#x00B0;C until use. SOD, GSH-Px, CAT activities, and the content of MDA (<xref ref-type="bibr" rid="B23">Liao et al., 2020</xref>; <xref ref-type="bibr" rid="B15">Homma et al., 2021</xref>; <xref ref-type="bibr" rid="B26">Liu et al., 2021</xref>)were determined according to manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="S2.SS8">
<title>Histology</title>
<p>The animals were anesthetized and decapitated, and brains were collected. The brain sample was embedded in paraffin, coronally sliced at 5-&#x03BC;m, and measured by HE staining (<xref ref-type="bibr" rid="B71">Zhang L. et al., 2021</xref>), and terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) staining (<xref ref-type="bibr" rid="B19">Lee et al., 2021</xref>). The areas around five randomly selected injury sites were quantified. Images were acquired by an Olympus CX41 microscope and analyzed by Image-Pro Plus.</p>
</sec>
<sec id="S2.SS9">
<title>Prediction of the Targets of Total Flavonoids of Chuju</title>
<p>The chemical compositions of TFCJ were identified from Traditional Chinese Medicine Systems Pharmacology database and analysis platform (TCMSP<sup><xref ref-type="fn" rid="footnote1">1</xref></sup>) (<xref ref-type="bibr" rid="B47">Ru et al., 2014</xref>), Integrative Pharmacology-Based Research Platform of Traditional Chinese Medicine (TCMIP<sup><xref ref-type="fn" rid="footnote2">2</xref></sup>) (<xref ref-type="bibr" rid="B60">Xu et al., 2019</xref>), and Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM<sup><xref ref-type="fn" rid="footnote3">3</xref></sup>) (<xref ref-type="bibr" rid="B29">Liu et al., 2016</xref>). The compound targets were downloaded from PharmMapper database<sup><xref ref-type="fn" rid="footnote4">4</xref></sup> (<xref ref-type="bibr" rid="B56">Wang et al., 2017</xref>).</p>
</sec>
<sec id="S2.SS10">
<title>Prediction of IS-Related Targets</title>
<p>The key words &#x2018;&#x2018;brain infarction,&#x2019;&#x2019; &#x2018;&#x2018;cerebral ischemia,&#x2019;&#x2019; &#x2018;&#x2018;cerebral infarction,&#x2019;&#x2019; and &#x2018;&#x2018;stroke&#x2019;&#x2019; were input into the following GeneCards database<sup><xref ref-type="fn" rid="footnote5">5</xref></sup>, OMIM database<sup><xref ref-type="fn" rid="footnote6">6</xref></sup> (<xref ref-type="bibr" rid="B3">Amberger et al., 2015</xref>), and DisGeNET database<sup><xref ref-type="fn" rid="footnote7">7</xref></sup> (<xref ref-type="bibr" rid="B42">Pi&#x00F1;ero et al., 2020</xref>) to search for IS-related targets.</p>
</sec>
<sec id="S2.SS11">
<title>Network Construction and Analysis</title>
<p>The common TFCJ and IS-related targets were uploaded to the String11.0 database<sup><xref ref-type="fn" rid="footnote8">8</xref></sup> (<xref ref-type="bibr" rid="B51">Szklarczyk et al., 2019</xref>), the type was set to &#x201C;Homo sapiens,&#x201D; the confidence level was set to &#x003E;0.700. Protein&#x2013;protein interactions (PPI) network and herb-compound-target-disease network were constructed by Cytoscape 3.7.2(<xref ref-type="bibr" rid="B48">Shannon et al., 2003</xref>).</p>
</sec>
<sec id="S2.SS12">
<title>Gene Set Enrichment Analysis</title>
<p>The common TFCJ and IS targets were uploaded to the DAVID 6.8 databases<sup><xref ref-type="fn" rid="footnote9">9</xref></sup> (<xref ref-type="bibr" rid="B16">Huang da et al., 2009</xref>) that used to analyze the GO and KEGG pathways enrichment of common targets. In our work, GO and KEGG terms with <italic>P</italic> &#x003C; 0.01 were considered as significantly enrichment analyses.</p>
</sec>
<sec id="S2.SS13">
<title>Oxidative Stress Evaluation</title>
<p>The brain hemisphere ipsilateral to MCAO was homogenized with pre-cooled physiological salt, and the supernatant was collected and stored in the refrigerator at &#x2212;80&#x00B0;C until use. SOD, GSH-Px, CAT activities, and the content of MDA were determined according to manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="S2.SS14">
<title>Real-Time Quantitative PCR</title>
<p>Total RNA of the ischemic penumbra of brain tissue was extracted using RNA isolater Total RNA Extraction Reagent (R401-01, Vazyme, Nanjing, China). The isolated RNA samples were reverse transcribed using HiScript<sup>&#x00AE;</sup> QRT SuperMix for qPCR (R122-01, Vazyme, Nanjing, China) following standard techniques.</p>
<p>Data of BCL-2, BAX, and cleaved-Caspase-3 mRNA were normalized to &#x03B2;-actin mRNA (<xref ref-type="table" rid="T1">Table 1</xref>). RT-PCR was performed using a quantitative ChamQ Universal SYBR qPCR Master Mix (Q711-02, Vazyme, Nanjing, China).</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Primers for real-time quantitative PCR (RT-PCR) in this study.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Gene</td>
<td valign="top" align="left">Primer names</td>
<td valign="top" align="left">Primer sequences</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">BCL-2</td>
<td valign="top" align="left">Primer_F</td>
<td valign="top" align="left">CTTCTCTCGTCGCTACCGTC</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Primer_R</td>
<td valign="top" align="left">CAATCCTCCCCCAGTTCACC</td>
</tr>
<tr>
<td valign="top" align="left">BAX</td>
<td valign="top" align="left">Primer_F</td>
<td valign="top" align="left">GAACCATCATGGGCTGGACA</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Primer_R</td>
<td valign="top" align="left">GTGAGTGAGGCAGTGAGGAC</td>
</tr>
<tr>
<td valign="top" align="left">Cleaved-Caspase-3</td>
<td valign="top" align="left">Primer_F</td>
<td valign="top" align="left">CGGACCTGTGGACCTGAAAA</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Primer_R</td>
<td valign="top" align="left">AGTCAGACTCCGGCAGTAGT</td>
</tr>
<tr>
<td valign="top" align="left">&#x03B2;-actin</td>
<td valign="top" align="left">Primer_F</td>
<td valign="top" align="left">CCCATCTATGAGGGTTACGC</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Primer_R</td>
<td valign="top" align="left">TTTAATGTCACGCACGATTT</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="S2.SS15">
<title>Western Blot</title>
<p>We performed Western blot analysis following previously described protocols (<xref ref-type="bibr" rid="B1">Abbruzzese et al., 2020</xref>). The total proteins in the cerebral ischemia-reperfusion brain were purified, centrifuged, and collected in the supernatant. The protein concentrations were quantified with a bicinchoninic acid (BCA) protein assay kit (P0010, Beyotime, Shanghai, China). The protein samples were first loaded into 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to polyvinylidene fluoride (PVDF) membranes. After blocking with 5% fat-free milk or BSA for 1 h, the PVDF membranes were incubated with primary antibodies at 4&#x00B0;C overnight (<xref ref-type="table" rid="T2">Table 2</xref>), following incubation with HRP-conjugated goat anti-mouse secondary polyclonal antibody (1:5000, 66009-1-Ig, Proteintech, Wuhan, China) for 2 h at room temperature. The protein bands were visualized using enhanced chemiluminescence (ECL), &#x03B2;-actin served as a loading control, and densitometric analysis was determined by ImageJ software. The ratio of the OD of the target protein to &#x03B2;-actin was used to represent the relative expression levels of the target proteins.</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>Primary antibodies for Western blot in this study.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Primary antibodies</td>
<td valign="top" align="center">Dilution</td>
<td valign="top" align="center">Company</td>
<td valign="top" align="center">Catalog</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Anti-AKT</td>
<td valign="top" align="center">1:1000</td>
<td valign="top" align="center">Proteintech</td>
<td valign="top" align="center">10176-2-AP</td>
</tr>
<tr>
<td valign="top" align="left">Anti-mTOR</td>
<td valign="top" align="center">1:3000</td>
<td valign="top" align="center">Proteintech</td>
<td valign="top" align="center">20657-1-AP</td>
</tr>
<tr>
<td valign="top" align="left">Anti-phospho-AKT (Ser473)</td>
<td valign="top" align="center">1:2000</td>
<td valign="top" align="center">Proteintech</td>
<td valign="top" align="center">66444-1-Ig</td>
</tr>
<tr>
<td valign="top" align="left">Anti-phospho-mTOR (Ser2448)</td>
<td valign="top" align="center">1:2000</td>
<td valign="top" align="center">Proteintech</td>
<td valign="top" align="center">67778-1-Ig</td>
</tr>
<tr>
<td valign="top" align="left">Anti-BCL-2</td>
<td valign="top" align="center">1:1000</td>
<td valign="top" align="center">Proteintech</td>
<td valign="top" align="center">12789-1-AP</td>
</tr>
<tr>
<td valign="top" align="left">Anti-BAX</td>
<td valign="top" align="center">1:3000</td>
<td valign="top" align="center">Proteintech</td>
<td valign="top" align="center">50599-2-Ig</td>
</tr>
<tr>
<td valign="top" align="left">Anti-cleaved-caspase-3</td>
<td valign="top" align="center">1:1000</td>
<td valign="top" align="center">CST</td>
<td valign="top" align="center">#9661</td>
</tr>
<tr>
<td valign="top" align="left">Anti-&#x03B2;-actin</td>
<td valign="top" align="center">1:5000</td>
<td valign="top" align="center">Proteintech</td>
<td valign="top" align="center">66009-1-Ig</td>
</tr>
<tr>
<td valign="top" align="left">HRP-conjugated goat anti-mouse secondary polyclonal antibody</td>
<td valign="top" align="center">1:5000</td>
<td valign="top" align="center">Proteintech</td>
<td valign="top" align="center">66009-1-Ig</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="S2.SS16">
<title>Statistical Analysis</title>
<p>All data were expressed as mean &#x00B1; SD; SPSS 25.0 statistical software (IBM SPSS Statistics for Windows, IBM Corp.) was adopted for all statistical analyses. The multiple variables were performed by one-way analysis of variance (ANOVA), and student&#x2019;s <italic>t</italic>-tests were used for comparison of variable pairs. <italic>P</italic> &#x003C; 0.05 was considered as statistically significant.</p>
</sec>
</sec>
<sec id="S3" sec-type="results">
<title>Results</title>
<sec id="S3.SS1">
<title>Total Flavonoids of Chuju Alleviates Nerve Injury</title>
<p>The neurological deficit scores and cerebral infarction area were evaluated (<xref ref-type="fig" rid="F1">Figure 1</xref>) after reperfusion for 24 h. The neurological deficit scores in the MCAO group were higher than that in the sham group (<xref ref-type="fig" rid="F1">Figure 1A</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01); the neurological deficits in the rats pre-treated with TFCJ (10, 20, and 40 mg&#x22C5;kg<sup>&#x2013;1</sup>) were significantly lower than those in the MCAO group (see <xref ref-type="fig" rid="F1">Figure 1A</xref>, &#x002A;<italic>P</italic> &#x003C; 0.05, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01); the neurological deficit scores in the Xuesaitong group significantly decreased compared to the MCAO group (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>The protective effects of total flavonoids of Chuju (TFCJ) on middle cerebral artery occlusion (MCAO) inducing brain injury. <bold>(A)</bold> Effects of TFCJ on the neurofunctional score. <bold>(B)</bold> Effects of TFCJ on the infarction size. Results were shown as mean &#x00B1; SD (<italic>n</italic> = 10, n, numbers of rats), <sup>#</sup><italic>P</italic> &#x003C; 0.05; <sup>##,&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-15-772401-g001.tif"/>
</fig>
<p>The sham group had a smaller cerebral infarct area, while the MCAO group had a bigger infarct area (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01). Cerebral infarct area in three dose groups of TFCJ was much lower than MCAO group (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01). The cerebral infarct area in the Xuesaitong group was significantly decreased than the MCAO group (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01).</p>
</sec>
<sec id="S3.SS2">
<title>Total Flavonoids of Chuju Reduces Oxidative Stress in Middle Cerebral Artery Occlusion Rats</title>
<p>The activity of SOD, GSH-Px, and CAT in the brain tissue and serum were lower in the MCAO group than in the sham group (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;C,E&#x2013;G</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01), and the concentration of MDA was higher in the MCAO group than in sham group (<xref ref-type="fig" rid="F2">Figures 2D,H</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01), indicating that MCAO induced oxidative stress in the brain tissue and serum.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Effects of TFCJ on MCAO inducing oxidative stress. <bold>(A)</bold> SOD activity (Group A: brain tissue); <bold>(B)</bold> GSH-Px activity (Group A: brain tissue); <bold>(C)</bold> CAT activity (Group A: brain tissue); <bold>(D)</bold> the MDA level (Group A: brain tissue); <bold>(E)</bold> SOD activity (Group B: serum); <bold>(F)</bold> GSH-Px activity (Group B: serum); <bold>(G)</bold> CAT activity (Group B: serum); <bold>(H)</bold> MDA activity (Group B: serum). Results were showed as mean &#x00B1; SD (<italic>n</italic> = 10), <sup>#</sup><italic>P</italic> &#x003C; 0.05; <sup>##,&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-15-772401-g002.tif"/>
</fig>
<p>The activity of SOD, GSH-Px, and CAT in the brain tissue and serum of high and middle dose groups of TFCJ was much greater than the MCAO group (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;C,E&#x2013;G</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01). The concentration of MDA in the brain tissue and serum of the three-dose groups of TFCJ was significantly lower compared to the MCAO group (<xref ref-type="fig" rid="F2">Figures 2D,H</xref>, &#x002A;<italic>P</italic> &#x003C; 0.05, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01).</p>
<p>Compared with the MCAO group, the activity of SOD and GSH-Px in the serum of the TFCJ-L group was significantly improved (<xref ref-type="fig" rid="F2">Figures 2E,F</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01), and the activity of CAT in the serum and brain tissue was significantly increased (<xref ref-type="fig" rid="F2">Figures 2C,G</xref>, &#x002A;<italic>P</italic> &#x003C; 0.05).</p>
<p>Compared with the MCAO group, the activity of SOD, GSH-Px, and CAT in the brain tissue and serum of the Xuesaitong group was significantly improved (<xref ref-type="fig" rid="F2">Figures 2A&#x2013;C,E&#x2013;G</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01), and the concentration of MDA was significantly decreased (<xref ref-type="fig" rid="F2">Figures 2D,H</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01).</p>
</sec>
<sec id="S3.SS3">
<title>Total Flavonoids of Chuju Alleviates Pathomorphological Changes in Middle Cerebral Artery Occlusion Rats</title>
<p>The structure of hippocampal neurons was intact in the sham group; the cells were regularly arranged and abundant in the cytoplasm; the cell nucleolus was large and obvious, and there was no pyknosis in the nucleus. Contrary, compared to the sham group, the neurons were disordered, and the cells were round vacuoles in the MCAO group. The arrangement of neuronal cells in the three-dose groups of TFCJ was regular, and the cell morphology was improved compared to the MCAO group (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Compared to the MCAO group, the neurons were neatly arranged, and the cell morphology was improved in the Xuesaitong group (<xref ref-type="fig" rid="F3">Figure 3A</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>The protective effects of TFCJ on MCAO inducing histology changes. <bold>(A)</bold> Micrographs of HE staining, and TUNEL staining. <bold>(B)</bold> Effects of TFCJ on the numbers of TUNEL positive neurons. Results were showed as mean &#x00B1; SD (<italic>n</italic> = 5), <sup>##,&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-15-772401-g003.tif"/>
</fig>
</sec>
<sec id="S3.SS4">
<title>Total Flavonoids of Chuju Treatment Decreases Neuronal Apoptosis</title>
<p>The nucleus was stained in blue, and the TUNEL-positive neurons were brown. Almost no neuronal death was observed in the sham group. The numbers of TUNEL-positive neurons were significantly higher in the MCAO group than in the sham group (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01), while they were reduced in the TFCJ group (<xref ref-type="fig" rid="F3">Figure 3B</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01). Compared to the MCAO group, the numbers of TUNEL-positive neurons were significantly lower in the Xuesaitong group (<xref ref-type="fig" rid="F3">Figure 3B</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01).</p>
</sec>
<sec id="S3.SS5">
<title>The Predictive Target of Total Flavonoids of Chuju</title>
<p>The 12 compounds [luteolin, quercetin, isorhamnetin, kaempferol, acacetin, eupatorin, 5, 7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl) chroman-4-one, linarin, diosmetin, chryseriol, naringenin, and artemetin in TFCJ are described in <xref ref-type="supplementary-material" rid="TS1">Supplementary Table 1</xref>]. The results retrieved from the PharmMapper databases were integrated to obtain the 300 targets with the highest matching degree with the 12 active TFCJ compounds. After deduplication, all information were merged, resulting in a database of 395 targets of TFCJ.</p>
</sec>
<sec id="S3.SS6">
<title>Construction of the Protein&#x2013;Protein Interactions and &#x201C;Herb-Compound-Target-Disease&#x201D; Relationship Network</title>
<p>IS-related targets were identified from GeneCards, OMIM, and DisGeNET databases. After deduplication, all information were merged, resulting in a database of 5,111 IS-related targets, including 934 common targets (<xref ref-type="fig" rid="F4">Figure 4A</xref>). A total of 247 common targets of TFCJ-anti-IS were identified using a Venn tool. The network was constructed with the String 11.0 database ignored disconnected targets, resulting in the PPI network of only 223 targets (<xref ref-type="fig" rid="F4">Figure 4B</xref>). The top ten targets, selected according to the degree of the PPI network, were MAPK1, Akt1, PIK3R1, SRC, EGFR, MAPK8, HRAS, HSP90AA1, IGF1, and RHOA (<xref ref-type="fig" rid="F4">Figure 4C</xref>). The herb-compound-target-disease network was composed of one herb, 12 compounds, 247 targets, and one disease. A diagram of this network is shown in <xref ref-type="fig" rid="F4">Figure 4D</xref>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Analysis of TFCJ compound-target network. <bold>(A)</bold> The Venny genes of IS. <bold>(B)</bold> The Venny and PPI network target genes of TFCJ anti IS. <bold>(C)</bold> The network for core target connection. <bold>(D)</bold> Herb-compound-target- disease network. <bold>(E)</bold> The GO enrichment analysis of 247 nodes. <bold>(F)</bold> Top 20 of the KEGG enrichment analysis.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-15-772401-g004.tif"/>
</fig>
</sec>
<sec id="S3.SS7">
<title>GO Enrichment Analysis and KEGG Pathway Analysis</title>
<p>We further analyzed the 247 targets of TFCJ-anti-IS using the David database. A total of 395 biological processes (BP), 50 cellular components (CC), 108 molecular functions (MF), and 110 KEGG pathways met the screening criteria of <italic>P</italic>-value &#x003C; 0.05 (<xref ref-type="supplementary-material" rid="TS2">Supplementary Tables 2</xref>&#x2013;<xref ref-type="supplementary-material" rid="TS5">5</xref>). The top ten terms of MF were identical protein binding, enzyme binding, receptor binding, serine-type endopeptidase activity, protein tyrosine kinase activity, kinase activity, steroid hormone receptor activity, RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding, transmembrane receptor protein tyrosine kinase activity, and non-membrane spanning protein tyrosine kinase activity. The top ten terms of CC were cytosol, extracellular exosome, plasma membrane, extracellular region, extracellular space, focal adhesion, extracellular matrix, membrane raft, blood microparticle, and an extrinsic component of cytoplasmic side of the plasma membrane. The top ten terms of BP were proteolysis, negative regulation of the apoptotic process, protein autophosphorylation, peptidyl-tyrosine phosphorylation, transcription initiation from RNA polymerase II promoter, response to hypoxia, steroid hormone mediated signaling pathway, phosphatidylinositol-mediated signaling, peptidyl-tyrosine autophosphorylation, and cellular response to insulin stimulus (<xref ref-type="fig" rid="F4">Figure 4E</xref>).</p>
<p>The top 20 terms of KEGG pathways were pathways in cancer, PI3K-Akt signaling pathway, Ras signaling pathway, proteoglycans in cancer, Rap1 signaling pathway, FoxO signaling pathway, insulin signaling pathway, estrogen signaling pathway, pancreatic cancer, thyroid hormone signaling pathway, prolactin signaling pathway, prostate cancer, colorectal cancer, VEGF signaling pathway, central carbon metabolism in cancer, Fc epsilon RI signaling pathway, adherens junction, chronic myeloid leukemia, PPAR signaling pathway, and non-small cell lung cancer (<xref ref-type="fig" rid="F4">Figure 4F</xref>).</p>
</sec>
<sec id="S3.SS8">
<title>The Protein Expression of PI3K/AKT/mTOR Pathway Mediated by Total Flavonoids of Chuju</title>
<p>The first part of the article found that TFCJ has a brain-protective effect and was related to the inhibition of oxidative stress and cell apoptosis. As the top 20 of the KEGG pathway, the PI3K-Akt signaling pathway has an important role in apoptosis and oxidative stress. Therefore, we focused on the regulation of TFCJ on the PI3K-Akt signal pathway and its downstream mTOR signal pathway (the 86th position of the KEGG pathway).</p>
<p>The p-Akt and p-mTOR expression in the MCAO control rats were significantly lower than in the sham rats (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01). The p-Akt and p-mTOR expression in the TFCJ treatment rats were significantly higher than in the MCAO control rats (<xref ref-type="fig" rid="F5">Figure 5B</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01). After using LY294002, the TFCJ treatment was reversed (see <xref ref-type="fig" rid="F5">Figure 5B</xref>, <sup>&#x25B2;&#x25B2;</sup><italic>P</italic> &#x003C; 0.01). There was no significant change in total Akt and mTOR protein expression in each group (<italic>P</italic> &#x003E; 0.05).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>The effects of TFCJ on PI3K/Akt/mTOR pathway. <bold>(A)</bold> The Akt, mTOR, p-Akt, and p-mTOR expression were measured using Western blotting. <bold>(B)</bold> The data of Akt, mTOR, p-Akt, and p-mTOR expression. Results were shown as mean &#x00B1; SD (<italic>n</italic> = 5), <sup>##,&#x002A;&#x002A;,&#x25B2;&#x25B2;</sup><italic>P</italic> &#x003C; 0.01.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-15-772401-g005.tif"/>
</fig>
</sec>
<sec id="S3.SS9">
<title>Total Flavonoids of Chuju Reduces Oxidative Stress Through PI3K/AKT/mTOR Pathway</title>
<p>Compared with the sham group, the activities of SOD (<xref ref-type="fig" rid="F6">Figure 6A</xref>), GSH-Px (<xref ref-type="fig" rid="F6">Figure 6B</xref>), and CAT (<xref ref-type="fig" rid="F6">Figure 6C</xref>) in the serum were significantly reduced in the MCAO control animals compared with the sham animals, while the level of MDA (<xref ref-type="fig" rid="F6">Figure 6D</xref>) was significantly increased (<xref ref-type="fig" rid="F6">Figures 6A&#x2013;D</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01). In the TFCJ treatment animals, GSH-Px (<xref ref-type="fig" rid="F6">Figure 6B</xref>) and CAT (<xref ref-type="fig" rid="F6">Figure 6C</xref>) activities were higher, while the MDA level (<xref ref-type="fig" rid="F6">Figure 6D</xref>) was lower compared to MCAO control (<xref ref-type="fig" rid="F6">Figures 6A&#x2013;D</xref>, <sup>&#x002A;&#x002A;</sup><italic>P</italic> &#x003C; 0.01). After using LY294002, the effect of TFCJ was reversed (<xref ref-type="fig" rid="F6">Figures 6A&#x2013;D</xref>, <sup>&#x25B2;&#x25B2;</sup><italic>P</italic> &#x003C; 0.01). The result showed that TFCJ could inhibit oxidative stress caused by MCAO in the serum through PI3K/Akt/mTOR pathway.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p>Effects of TFCJ on MCAO inducing oxidative stress. <bold>(A)</bold> SOD activity; <bold>(B)</bold> GSH-Px activity; <bold>(C)</bold> CAT activity; <bold>(D)</bold> MDA level. Results were shown as mean &#x00B1; SD (<italic>n</italic> = 10), <sup>#</sup><italic>P</italic> &#x003C; 0.05, <sup>##</sup><italic>P</italic> &#x003C; 0.01 vs. sham group. <sup>##,&#x002A;&#x002A;,&#x25B2;&#x25B2;</sup><italic>P</italic> &#x003C; 0.01.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-15-772401-g006.tif"/>
</fig>
</sec>
<sec id="S3.SS10">
<title>Total Flavonoids of Chuju Inhibited Apoptosis Through PI3K/AKT/mTOR Pathway</title>
<p>As shown in <xref ref-type="fig" rid="F7">Figure 7</xref>, the BCL-2 protein expression was reduced after IS 24h (<xref ref-type="fig" rid="F7">Figure 7A</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01), whereas TFCJ upregulated BCL-2 protein expression (<xref ref-type="fig" rid="F7">Figure 7A</xref>, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01). The BAX and cleaved-Caspase-3 expression were increased after IS 24h (<xref ref-type="fig" rid="F7">Figure 7A</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01), whereas TFCJ upregulated BAX and cleaved-Caspase-3 protein expression (<xref ref-type="fig" rid="F7">Figure 7A</xref>, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01). After using LY294002, the TFCJ treatment was reversed (see <xref ref-type="fig" rid="F7">Figure 7A</xref>, <sup>&#x25B2;&#x25B2;</sup><italic>P</italic> &#x003C; 0.01). Moreover, RT-PCR analysis indicated that MCAO reduced the expression of BCL-2 and increased the level of BAX and cleaved-Caspase-3 (<xref ref-type="fig" rid="F7">Figure 7B</xref>, <sup>##</sup><italic>P</italic> &#x003C; 0.01), while TFCJ induced the expression of BCL-2 and decreased the level of BAX and cleaved-Caspase-3 (<xref ref-type="fig" rid="F7">Figure 7B</xref>, &#x002A;&#x002A;<italic>P</italic> &#x003C; 0.01). After using LY294002, the effect of TFCJ was significantly reversed (<xref ref-type="fig" rid="F7">Figure 7B</xref>, <sup>&#x25B2;&#x25B2;</sup><italic>P</italic> &#x003C; 0.01).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption><p>The effects of TFCJ on BCL-2, BAX, and cleaved-Caspase-3 expression. <bold>(A,B)</bold> The apoptosis-related factors measured using Western blotting. <bold>(C)</bold> The data of RT-PCR in apoptosis-related factors. Results were shown as mean &#x00B1; SD (<italic>n</italic> = 5), <sup>#</sup><italic>P</italic> &#x003C; 0.05, <sup>##</sup><italic>P</italic> &#x003C; 0.01 vs. sham group. <sup>##,&#x002A;&#x002A;,&#x25B2;&#x25B2;</sup><italic>P</italic> &#x003C; 0.01.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnins-15-772401-g007.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>This study evaluated the neuroprotective effect of TFCJ against IS in rats. We hypothesized that TFCJ might exert its neuroprotective effects by suppressing apoptosis and oxidative stress by activating the PI3K/Akt/mTOR signaling pathway. The important predictors of IS are the neurological deficit scores and cerebral infarction (<xref ref-type="bibr" rid="B69">Zhang H. et al., 2020</xref>; <xref ref-type="bibr" rid="B24">Lin et al., 2021</xref>; <xref ref-type="bibr" rid="B54">Wang et al., 2021</xref>). In this study, rats were subjected to middle cerebral artery occlusion (MCAO) for 2 h and reperfusion for 24 h. In the early phase (first few minutes to a few hours) after intracerebral artery occlusion, the infarcted area containing ischemic tissue gradually spreads outwards. With time, the ability of brain tissue to recovery gradually decreases (<xref ref-type="bibr" rid="B44">Prabhakaran et al., 2015</xref>). In this study, MCAO rats showed typical IS features, including a dramatic increase of neurological deficit scores and cerebral infarction. Our data also showed that TFCJ could effectively improve neurological function and reduce the area of cerebral infarction. Moreover, in the MCAO rats, HE staining experiments showed that the neurons were arranged in a disorderly manner, and the cells were around vacuoles, while the arrangement of neuronal cells was regular, and the cell morphology was improved with the aid of TFCJ.</p>
<p>Next, we explored the underlying mechanism of TFCJ against IS. Previous studies (<xref ref-type="bibr" rid="B70">Zhang et al., 2019</xref>; <xref ref-type="bibr" rid="B14">Heidari et al., 2021</xref>; <xref ref-type="bibr" rid="B31">Luo et al., 2021</xref>) have reported that oxidative stress and cell apoptosis may have the strongest correlation with IS. <xref ref-type="bibr" rid="B22">Li et al. (2021)</xref> reported that miR-27A-3p reduces apoptosis and oxidative stress induced by oxygen-glucose deprivation/reoxygenation through FOXO1/p27 Kip1 signaling. Moreover, <xref ref-type="bibr" rid="B63">Yip et al. (2021)</xref> reported that melatonin reduces apoptotic oxidative stress by repairing impaired metabolic-redox circuits in IS.</p>
<p>GSH-Px is the main antioxidant that interacts with lipid hydrogen peroxide (<xref ref-type="bibr" rid="B71">Zhang L. et al., 2021</xref>). The degree of cerebral ischemia, hypoxia, and necrosis is related to the level of GSH-Px. The increase of GSH-Px levels can inhibit IS. SOD can have a role by scavenging oxygen free radicals in the body (<xref ref-type="bibr" rid="B71">Zhang L. et al., 2021</xref>). CAT can disproportionate and decompose oxygen free radicals to produce H<sub>2</sub>O<sub>2</sub> through SOD disproportionation to avoid cytotoxicity (<xref ref-type="bibr" rid="B58">Wattanathorn et al., 2020</xref>). MDA is the final product of oxygen-derived free radicals and lipid peroxidation and an important sign of oxidative damage (<xref ref-type="bibr" rid="B10">Du et al., 2020</xref>). To assess the level of oxidative stress, we found that SOD, GSH-Px, CAT activities were reduced, while MDA level was increased in the serum and cerebral ischemic region after IS (after 24 h); while this effect was reversed by TFCJ. The results of TUNEL staining experiments showed that TFCJ markedly attenuated neuronal apoptosis, thus suggesting that TFCJ could regulate apoptosis after MCAO.</p>
<p>Then, potential targets and pathways of TFCJ were screened by network pharmacology. A total of 12 compounds of TFCJ were collected. We predicted 395 targets according to their structure and screened 5111 targets of IS. Finally, 247 common targets were obtained by a Venny tool. A total of 395 biological processes, 50 cellular components, 108 molecular functions, and 110 KEGG pathways were obtained by GO and KEGG analysis of 247 common targets.</p>
<p>PI3K/Akt/mTOR is a multifunctional signaling pathway associated with anti-apoptosis and anti-oxidant stress. Phosphorylation of Akt and mTOR were suppressed in the late stage of IS. Akt and mTOR overexpression improved the protective effects after cerebral ischemia-reperfusion injury in MCAO rats, suggesting that the activation of the PI3K/Akt/mTOR signaling pathway provides significant neuroprotective effects against cerebral ischemia-reperfusion injury. P-Akt and p-mTOR (<xref ref-type="bibr" rid="B20">Li et al., 2016</xref>; <xref ref-type="bibr" rid="B61">Yang et al., 2017</xref>; <xref ref-type="bibr" rid="B41">Park et al., 2019</xref>; <xref ref-type="bibr" rid="B50">Sun et al., 2020</xref>) are commonly recognized as markers for activation of the PI3K/Akt/mTOR pathway. In the present study, the levels of p-AKT and p-mTOR were significantly decreased following I/R injury and were activated by TFCJ treatment.</p>
<p>To further explore the molecular mechanisms underlying the TFCJ anti-apoptosis and anti-oxidant stress effect, we detected the expression changes of mediators of apoptosis and oxidant stress involved in ischemic brain damage under the inhibitory condition of PI3K/Akt/mTOR signaling pathway. BCL-2 is a type of anti-apoptotic protein, while BAX and cleaved-Caspase-3 are known to promote apoptosis (<xref ref-type="bibr" rid="B53">Veleta et al., 2020</xref>; <xref ref-type="bibr" rid="B59">Wei et al., 2020</xref>). The protein expression of BCL-2, BAX, and cleaved-Caspase-3 were detected by using western blot to evaluate the degree of apoptosis. The levels of BCL-2, SOD, CAT, and GSH-Px significantly decreased, while BAX, cleaved-Caspase-3, and MDA levels were increased following I/R injury; this process was reversed by TFCJ treatment. Moreover, the effect of TFCJ was significantly reversed when applying LY294002 (PI3k inhibitor).</p>
<p>In summary, our data suggested that TFCJ might decrease nerve damage in rat cerebral ischemia by regulating the PI3K/Akt signaling pathway. The findings of this study provide a reference for the clinical anti-apoptosis, anti-oxidant stress, and neuroprotection of TFCJ. In our future studies, we plan to further assess the effects of TFCJ on cell apoptosis and oxidative stress <italic>in vitro</italic>.</p>
</sec>
<sec id="S5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="DS1">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="S6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by Anhui Science and Technology University institutional animal care. Written informed consent was obtained from the owners for the participation of their animals in this study.</p>
</sec>
<sec id="S7">
<title>Author Contributions</title>
<p>CW, HC, B-BM, and HY contributed to conception and design of the study. CW organized the database and wrote the first draft of the manuscript. CW and H-HJ performed the statistical analysis. H-HJ wrote sections of the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version.</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="pudiscl1" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="S8" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by the Collaborative Innovation Project of Colleges and Universities in Anhui Province (GXXT-2019-043), the Key Research and Development Plan projects in Anhui Province (202004a07020031), and the Project of Natural Science Foundation of Anhui Province (2008085QH395).</p>
</sec>
<sec id="S9" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnins.2021.772401/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnins.2021.772401/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.docx" id="DS1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_1.docx" id="TS1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_2.docx" id="TS2" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_3.docx" id="TS3" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_4.docx" id="TS4" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_5.docx" id="TS5" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_6.docx" id="TS6" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abbruzzese</surname> <given-names>G.</given-names></name> <name><surname>Mor&#x00F3;n-Oset</surname> <given-names>J.</given-names></name> <name><surname>D&#x00ED;az-Castroverde</surname> <given-names>S.</given-names></name> <name><surname>Garc&#x00ED;a-Font</surname> <given-names>N.</given-names></name> <name><surname>Roncero</surname> <given-names>C.</given-names></name> <name><surname>L&#x00F3;pez-Mu&#x00F1;oz</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Neuroprotection by phytoestrogens in the model of deprivation and resupply of oxygen and glucose in vitro: the contribution of autophagy and related signaling mechanisms.</article-title> <source><italic>Antioxidants</italic></source> <volume>9</volume>:<fpage>545</fpage>. <pub-id pub-id-type="doi">10.3390/antiox9060545</pub-id> <pub-id pub-id-type="pmid">32580379</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allegaert</surname> <given-names>K.</given-names></name> <name><surname>De Hoon</surname> <given-names>J.</given-names></name> <name><surname>Debeer</surname> <given-names>A.</given-names></name> <name><surname>Gewillig</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Renal side effects of non-steroidal anti-inflammatory drugs in neonates.</article-title> <source><italic>Pharmaceuticals</italic></source> <volume>3</volume> <fpage>393</fpage>&#x2013;<lpage>405</lpage>.</citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amberger</surname> <given-names>J. S.</given-names></name> <name><surname>Bocchini</surname> <given-names>C. A.</given-names></name> <name><surname>Schiettecatte</surname> <given-names>F.</given-names></name> <name><surname>Scott</surname> <given-names>A. F.</given-names></name> <name><surname>Hamosh</surname> <given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>OMIM.org: online mendelian inheritance in man (OMIM<sup>&#x00AE;</sup>), an online catalog of human genes and genetic disorders.</article-title> <source><italic>Nucleic Acids Res.</italic></source> <volume>43</volume> <fpage>D789</fpage>&#x2013;<lpage>D798</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku1205</pub-id> <pub-id pub-id-type="pmid">25428349</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asati</surname> <given-names>V.</given-names></name> <name><surname>Mahapatra</surname> <given-names>D. K.</given-names></name> <name><surname>Bharti</surname> <given-names>S. K.</given-names></name></person-group> (<year>2016</year>). <article-title>PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives.</article-title> <source><italic>Eur. J. Med. Chem.</italic></source> <volume>109</volume> <fpage>314</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2016.01.012</pub-id> <pub-id pub-id-type="pmid">26807863</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname> <given-names>J.</given-names></name> <name><surname>Shi</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>H. Q.</given-names></name> <name><surname>Niu</surname> <given-names>X. S.</given-names></name> <name><surname>Zhao</surname> <given-names>Z. F.</given-names></name> <name><surname>Wu</surname> <given-names>W. D.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Acacetin protects against cerebral ischemia-reperfusion injury via the NLRP3 signaling pathway.</article-title> <source><italic>Neural Regen. Res.</italic></source> <volume>14</volume> <fpage>605</fpage>&#x2013;<lpage>612</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.247465</pub-id> <pub-id pub-id-type="pmid">30632500</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carvalhal</surname> <given-names>F.</given-names></name> <name><surname>Cristelo</surname> <given-names>R. R.</given-names></name> <name><surname>Resende</surname> <given-names>D.</given-names></name> <name><surname>Pinto</surname> <given-names>M. M. M.</given-names></name> <name><surname>Sousa</surname> <given-names>E.</given-names></name> <name><surname>Correia-da-Silva</surname> <given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Antithrombotics from the Sea: polysaccharides and beyond.</article-title> <source><italic>Mar. Drugs</italic></source> <volume>17</volume>:<fpage>170</fpage>. <pub-id pub-id-type="doi">10.3390/md17030170</pub-id> <pub-id pub-id-type="pmid">30884850</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Peng</surname> <given-names>J.</given-names></name> <name><surname>Sherchan</surname> <given-names>P.</given-names></name> <name><surname>Ma</surname> <given-names>Y.</given-names></name> <name><surname>Xiang</surname> <given-names>S.</given-names></name> <name><surname>Yan</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice.</article-title> <source><italic>J. Neuroinflammation</italic></source> <volume>17</volume>:<fpage>168</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-020-01853-x</pub-id> <pub-id pub-id-type="pmid">32466767</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornelius</surname> <given-names>C.</given-names></name> <name><surname>Crupi</surname> <given-names>R.</given-names></name> <name><surname>Calabrese</surname> <given-names>V.</given-names></name> <name><surname>Graziano</surname> <given-names>A.</given-names></name> <name><surname>Milone</surname> <given-names>P.</given-names></name> <name><surname>Pennisi</surname> <given-names>G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Traumatic brain injury: oxidative stress and neuroprotection.</article-title> <source><italic>Antioxid. Redox. Signal.</italic></source> <volume>19</volume> <fpage>836</fpage>&#x2013;<lpage>853</lpage>.</citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Di Costanzo</surname> <given-names>A.</given-names></name> <name><surname>Paris</surname> <given-names>D.</given-names></name> <name><surname>Melck</surname> <given-names>D.</given-names></name> <name><surname>Angiolillo</surname> <given-names>A.</given-names></name> <name><surname>Corso</surname> <given-names>G.</given-names></name> <name><surname>Maniscalco</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Blood biomarkers indicate that the preclinical stages of Alzheimer&#x2019;s disease present overlapping molecular features.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>10</volume>:<fpage>15612</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-71832-y</pub-id> <pub-id pub-id-type="pmid">32973179</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>J.</given-names></name> <name><surname>Yin</surname> <given-names>G.</given-names></name> <name><surname>Hu</surname> <given-names>Y.</given-names></name> <name><surname>Shi</surname> <given-names>S.</given-names></name> <name><surname>Jiang</surname> <given-names>J.</given-names></name> <name><surname>Song</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Coicis semen protects against focal cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting angiogenesis via the TGF&#x03B2;/ALK1/Smad1/5 signaling pathway.</article-title> <source><italic>Aging (Albany NY)</italic></source> <volume>13</volume> <fpage>877</fpage>&#x2013;<lpage>893</lpage>. <pub-id pub-id-type="doi">10.18632/aging.202194</pub-id> <pub-id pub-id-type="pmid">33290255</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>H. J.</given-names></name> <name><surname>Liu</surname> <given-names>P. F.</given-names></name> <name><surname>Li</surname> <given-names>P. W.</given-names></name> <name><surname>Huang</surname> <given-names>Z. Y.</given-names></name> <name><surname>Yu</surname> <given-names>F. B.</given-names></name> <name><surname>Lei</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Ligustrazine monomer against cerebral ischemia/reperfusion injury.</article-title> <source><italic>Neural Regen. Res.</italic></source> <volume>10</volume> <fpage>832</fpage>&#x2013;<lpage>840</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.156991</pub-id> <pub-id pub-id-type="pmid">26109963</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garbuzova-Davis</surname> <given-names>S.</given-names></name> <name><surname>Haller</surname> <given-names>E.</given-names></name> <name><surname>Tajiri</surname> <given-names>N.</given-names></name> <name><surname>Thomson</surname> <given-names>A.</given-names></name> <name><surname>Barretta</surname> <given-names>J.</given-names></name> <name><surname>Williams</surname> <given-names>S. N.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Blood-spinal cord barrier alterations in subacute and chronic stages of a rat model of focal cerebral Ischemia.</article-title> <source><italic>J. Neuropathol. Exp. Neurol.</italic></source> <volume>75</volume> <fpage>673</fpage>&#x2013;<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/nlw040</pub-id> <pub-id pub-id-type="pmid">27283328</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><collab>GBD 2019 Demographics Collaborators</collab> (<year>2020</year>). <article-title>Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global burden of disease study 2019.</article-title> <source><italic>Lancet</italic></source> <volume>396</volume> <fpage>1160</fpage>&#x2013;<lpage>1203</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30977-6</pub-id> <pub-id pub-id-type="pmid">34003294</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heidari</surname> <given-names>Z.</given-names></name> <name><surname>Mahmoudzadeh-Sagheb</surname> <given-names>H.</given-names></name> <name><surname>Sarbishegi</surname> <given-names>M.</given-names></name> <name><surname>Gorgich</surname> <given-names>E. A. C.</given-names></name></person-group> (<year>2021</year>). <article-title>Withania coagulans extract attenuates oxidative stress-mediated apoptosis of cerebellar purkinje neurons after ischemia/reperfusion injury.</article-title> <source><italic>Metab. Brain Dis.</italic></source> <volume>36</volume> <fpage>1699</fpage>&#x2013;<lpage>1708</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-021-00745-0</pub-id> <pub-id pub-id-type="pmid">33970396</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Homma</surname> <given-names>K.</given-names></name> <name><surname>Toda</surname> <given-names>E.</given-names></name> <name><surname>Osada</surname> <given-names>H.</given-names></name> <name><surname>Nagai</surname> <given-names>N.</given-names></name> <name><surname>Era</surname> <given-names>T.</given-names></name> <name><surname>Tsubota</surname> <given-names>K.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium.</article-title> <source><italic>Redox Biol.</italic></source> <volume>41</volume>:<fpage>101921</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2021.101921</pub-id> <pub-id pub-id-type="pmid">33706170</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang da</surname> <given-names>W.</given-names></name> <name><surname>Sherman</surname> <given-names>B. T.</given-names></name> <name><surname>Lempicki</surname> <given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.</article-title> <source><italic>Nat. Protoc.</italic></source> <volume>4</volume> <fpage>44</fpage>&#x2013;<lpage>57</lpage>.</citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joya</surname> <given-names>A.</given-names></name> <name><surname>Ardaya</surname> <given-names>M.</given-names></name> <name><surname>Montilla</surname> <given-names>A.</given-names></name> <name><surname>Garbizu</surname> <given-names>M.</given-names></name> <name><surname>Plaza-Garc&#x00ED;a</surname> <given-names>S.</given-names></name> <name><surname>G&#x00F3;mez-Vallejo</surname> <given-names>V.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke.</article-title> <source><italic>Theranostics</italic></source> <volume>11</volume> <fpage>410</fpage>&#x2013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.7150/thno.51046</pub-id> <pub-id pub-id-type="pmid">33391483</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanazawa</surname> <given-names>T.</given-names></name> <name><surname>Kurano</surname> <given-names>T.</given-names></name> <name><surname>Ibaraki</surname> <given-names>H.</given-names></name> <name><surname>Takashima</surname> <given-names>Y.</given-names></name> <name><surname>Suzuki</surname> <given-names>T.</given-names></name> <name><surname>Seta</surname> <given-names>Y.</given-names></name></person-group> (<year>2019</year>). <article-title>Therapeutic effects in a transient middle cerebral artery occlusion rat model by nose-to-brain delivery of anti-TNF-Alpha siRNA with cell-penetrating peptide-modified polymer micelles.</article-title> <source><italic>Pharmaceutics</italic></source> <volume>11</volume>:<fpage>689</fpage>.</citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>T. L.</given-names></name> <name><surname>Lai</surname> <given-names>T. C.</given-names></name> <name><surname>Lin</surname> <given-names>S. R.</given-names></name> <name><surname>Lin</surname> <given-names>S. W.</given-names></name> <name><surname>Chen</surname> <given-names>Y. C.</given-names></name> <name><surname>Pu</surname> <given-names>C. M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Conditioned medium from adipose-derived stem cells attenuates ischemia/reperfusion-induced cardiac injury through the microRNA-221/222/PUMA/ETS-1 pathway.</article-title> <source><italic>Theranostics</italic></source> <volume>11</volume> <fpage>3131</fpage>&#x2013;<lpage>3149</lpage>. <pub-id pub-id-type="doi">10.7150/thno.52677</pub-id> <pub-id pub-id-type="pmid">33537078</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Zhou</surname> <given-names>R.</given-names></name> <name><surname>Shan</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis.</article-title> <source><italic>Oncotarget</italic></source> <volume>7</volume> <fpage>58531</fpage>&#x2013;<lpage>58542</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.11325</pub-id> <pub-id pub-id-type="pmid">27542271</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>P.</given-names></name> <name><surname>Stetler</surname> <given-names>R. A.</given-names></name> <name><surname>Leak</surname> <given-names>R. K.</given-names></name> <name><surname>Shi</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Yu</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Oxidative stress and DNA damage after cerebral ischemia: potential therapeutic targets to repair the genome and improve stroke recovery.</article-title> <source><italic>Neuropharmacology</italic></source> <volume>134</volume> <fpage>208</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.11.011</pub-id> <pub-id pub-id-type="pmid">29128308</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Zhu</surname> <given-names>Q.</given-names></name> <name><surname>Xu</surname> <given-names>X.</given-names></name> <name><surname>Hu</surname> <given-names>X.</given-names></name></person-group> (<year>2021</year>). <article-title>MiR-27a-3p suppresses cerebral ischemia-reperfusion injury by targeting FOXO1.</article-title> <source><italic>Aging (Albany NY)</italic></source> <volume>13</volume> <fpage>11727</fpage>&#x2013;<lpage>11737</lpage>. <pub-id pub-id-type="doi">10.18632/aging.202866</pub-id> <pub-id pub-id-type="pmid">33875617</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>L.</given-names></name> <name><surname>Jiang</surname> <given-names>C.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Shi</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Synthesis and biological evaluation of 1,2,4-triazole derivatives as potential neuroprotectant against ischemic brain injury.</article-title> <source><italic>Eur. J. Med. Chem.</italic></source> <volume>190</volume>:<fpage>112114</fpage>.</citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>S. Y.</given-names></name> <name><surname>Wang</surname> <given-names>Y. Y.</given-names></name> <name><surname>Chang</surname> <given-names>C. Y.</given-names></name> <name><surname>Wu</surname> <given-names>C. C.</given-names></name> <name><surname>Chen</surname> <given-names>W. Y.</given-names></name> <name><surname>Liao</surname> <given-names>S. L.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>TNF-&#x03B1; receptor inhibitor alleviates metabolic and inflammatory changes in a rat model of ischemic stroke.</article-title> <source><italic>Antioxidants</italic></source> <volume>10</volume>:<fpage>851</fpage>. <pub-id pub-id-type="doi">10.3390/antiox10060851</pub-id> <pub-id pub-id-type="pmid">34073455</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>G.</given-names></name> <name><surname>Zheng</surname> <given-names>Q.</given-names></name> <name><surname>Pan</surname> <given-names>K.</given-names></name> <name><surname>Xu</surname> <given-names>X.</given-names></name></person-group> (<year>2020</year>). <article-title>Protective effect of <italic>Chrysanthemum morifolium</italic> Ramat. ethanol extract on lipopolysaccharide induced acute lung injury in mice.</article-title> <source><italic>BMC Complement Med. Ther.</italic></source> <volume>20</volume>:<fpage>235</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-020-03017-z</pub-id> <pub-id pub-id-type="pmid">32711512</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Xu</surname> <given-names>Z.</given-names></name> <name><surname>Song</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Cottonseed oil alleviates ischemic stroke-induced oxidative stress injury via activating the Nrf2 signaling pathway.</article-title> <source><italic>Mol. Neurobiol.</italic></source> <volume>58</volume> <fpage>2494</fpage>&#x2013;<lpage>2507</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-020-02256-y</pub-id> <pub-id pub-id-type="pmid">33443681</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>P.</given-names></name> <name><surname>Bai</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>T.</given-names></name> <name><surname>Zhou</surname> <given-names>L.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>The protective effect of <italic>Lonicera japonica</italic> polysaccharide on mice with depression by inhibiting NLRP3 inflammasome.</article-title> <source><italic>Ann. Transl. Med.</italic></source> <volume>7</volume>:<fpage>811</fpage>. <pub-id pub-id-type="doi">10.21037/atm.2019.12.64</pub-id> <pub-id pub-id-type="pmid">32042827</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>S.</given-names></name> <name><surname>Su</surname> <given-names>Y.</given-names></name> <name><surname>Sun</surname> <given-names>B.</given-names></name> <name><surname>Hao</surname> <given-names>R.</given-names></name> <name><surname>Pan</surname> <given-names>S.</given-names></name> <name><surname>Gao</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Luteolin protects against CIRI, potentially via regulation of the SIRT3/AMPK/mTOR signaling pathway.</article-title> <source><italic>Neurochem. Res.</italic></source> <volume>45</volume> <fpage>2499</fpage>&#x2013;<lpage>2515</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-020-03108-w</pub-id> <pub-id pub-id-type="pmid">32809175</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z.</given-names></name> <name><surname>Guo</surname> <given-names>F.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>BATMAN-TCM: a Bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>6</volume>:<fpage>21146</fpage>.</citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Longa</surname> <given-names>E. Z.</given-names></name> <name><surname>Weinstein</surname> <given-names>P. R.</given-names></name> <name><surname>Carlson</surname> <given-names>S.</given-names></name> <name><surname>Cummins</surname> <given-names>R.</given-names></name></person-group> (<year>1989</year>). <article-title>Reversible middle cerebral artery occlusion without craniectomy in rats.</article-title> <source><italic>Stroke</italic></source> <volume>20</volume> <fpage>84</fpage>&#x2013;<lpage>91</lpage>.</citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>Tsoi</surname> <given-names>B.</given-names></name> <name><surname>Wang</surname> <given-names>Q.</given-names></name> <name><surname>Shen</surname> <given-names>J.</given-names></name></person-group> (<year>2021</year>). <article-title>Danggui-Shaoyao-San (DSS) ameliorates cerebral ischemia-reperfusion injury via activating SIRT1 signaling and inhibiting NADPH oxidases.</article-title> <source><italic>Front. Pharmacol.</italic></source> <volume>12</volume>:<fpage>653795</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.653795</pub-id> <pub-id pub-id-type="pmid">33935765</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Niu</surname> <given-names>Z.</given-names></name> <name><surname>Song</surname> <given-names>J.</given-names></name> <name><surname>Lin</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.</article-title> <source><italic>Pharmacol. Res.</italic></source> <volume>107</volume> <fpage>291</fpage>&#x2013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2016.03.030</pub-id> <pub-id pub-id-type="pmid">27038532</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>Y. L.</given-names></name> <name><surname>Sun</surname> <given-names>P.</given-names></name> <name><surname>Feng</surname> <given-names>J.</given-names></name> <name><surname>Yuan</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Shang</surname> <given-names>Y. F.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Solvent effect on phenolics and antioxidant activity of Huangshan Gongju (Dendranthema morifolium (Ramat) Tzvel. cv. Gongju) extract.</article-title> <source><italic>Food Chem. Toxicol.</italic></source> <volume>147</volume>:<fpage>111875</fpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2020.111875</pub-id> <pub-id pub-id-type="pmid">33227389</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maiti</surname> <given-names>P.</given-names></name> <name><surname>Scott</surname> <given-names>J.</given-names></name> <name><surname>Sengupta</surname> <given-names>D.</given-names></name> <name><surname>Al-Gharaibeh</surname> <given-names>A.</given-names></name> <name><surname>Dunbar</surname> <given-names>G. L.</given-names></name></person-group> (<year>2019</year>). <article-title>Curcumin and solid lipid curcumin particles induce autophagy, but inhibit mitophagy and the PI3K-Akt/mTOR pathway in cultured glioblastoma cells.</article-title> <source><italic>Int. J. Mol. Sci.</italic></source> <volume>20</volume>:<fpage>399</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20020399</pub-id> <pub-id pub-id-type="pmid">30669284</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname> <given-names>C. G.</given-names></name> <name><surname>Chen</surname> <given-names>Q. Y.</given-names></name> <name><surname>He</surname> <given-names>H. Q.</given-names></name></person-group> (<year>2012</year>). <article-title>Antioxidant activity study of flavonoid of <italic>Dendranthema morifolium</italic> ramat.</article-title> <source><italic>J. Biol.</italic></source> <volume>29</volume> <fpage>42</fpage>&#x2013;<lpage>44</lpage>.</citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname> <given-names>W.</given-names></name> <name><surname>Yan</surname> <given-names>Y.</given-names></name> <name><surname>Bao</surname> <given-names>T. H.</given-names></name> <name><surname>Jia</surname> <given-names>W. J.</given-names></name> <name><surname>Yang</surname> <given-names>F.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124.</article-title> <source><italic>Biomed. Pharmacother.</italic></source> <volume>126</volume>:<fpage>109786</fpage>.</citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nian</surname> <given-names>S. H.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>Yu</surname> <given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Effect of Chuju total flavonoids on acute ischemia rats induced by isoproterenol.</article-title> <source><italic>Anhui Med. J.</italic></source> <volume>40</volume> <fpage>1306</fpage>&#x2013;<lpage>1309</lpage>.</citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname> <given-names>A.</given-names></name> <name><surname>Ago</surname> <given-names>T.</given-names></name> <name><surname>Kuroda</surname> <given-names>J.</given-names></name> <name><surname>Arimura</surname> <given-names>K.</given-names></name> <name><surname>Tachibana</surname> <given-names>M.</given-names></name> <name><surname>Nakamura</surname> <given-names>K.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Detrimental role of pericyte Nox4 in the acute phase of brain ischemia.</article-title> <source><italic>J. Cereb. Blood Flow Metab.</italic></source> <volume>36</volume> <fpage>1143</fpage>&#x2013;<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X15606456</pub-id> <pub-id pub-id-type="pmid">26661159</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olga Nikolaevna</surname> <given-names>O.</given-names></name> <name><surname>Evgeniya Aronovna</surname> <given-names>G.</given-names></name> <name><surname>Elena Igorevna</surname> <given-names>K.</given-names></name> <name><surname>Margarita Alekseevna</surname> <given-names>B.</given-names></name> <name><surname>Mikhail Vladimirovich</surname> <given-names>G.</given-names></name> <name><surname>Valery Gennadievich</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Intravenous administration of coenzyme Q10 in acute period of cerebral ischemia decreases mortality by reducing brain necrosis and limiting its increase within 4 days in rat stroke model.</article-title> <source><italic>Antioxidants</italic></source> <volume>9</volume>:<fpage>1240</fpage>. <pub-id pub-id-type="doi">10.3390/antiox9121240</pub-id> <pub-id pub-id-type="pmid">33297323</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>Q.</given-names></name> <name><surname>Zhao</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Zhao</surname> <given-names>K.</given-names></name> <name><surname>Zhai</surname> <given-names>Q.</given-names></name> <name><surname>Tu</surname> <given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Apigenin protects the brain against ischemia/reperfusion injury via Caveolin-1/VEGF in vitro and in vivo.</article-title> <source><italic>Oxid. Med. Cell Longev.</italic></source> <volume>2018</volume>:<fpage>7017204</fpage>. <pub-id pub-id-type="doi">10.1155/2018/7017204</pub-id> <pub-id pub-id-type="pmid">30622670</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>D. J.</given-names></name> <name><surname>Kang</surname> <given-names>J. B.</given-names></name> <name><surname>Shah</surname> <given-names>F. A.</given-names></name> <name><surname>Koh</surname> <given-names>P. O.</given-names></name></person-group> (<year>2019</year>). <article-title>Resveratrol modulates the Akt/GSK-3&#x03B2; signaling pathway in a middle cerebral artery occlusion animal model.</article-title> <source><italic>Lab. Anim. Res.</italic></source> <volume>35</volume>:<fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/s42826-019-0019-8</pub-id> <pub-id pub-id-type="pmid">32257906</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pi&#x00F1;ero</surname> <given-names>J.</given-names></name> <name><surname>Ram&#x00ED;rez-Anguita</surname> <given-names>J. M.</given-names></name> <name><surname>Sa&#x00FC;ch-Pitarch</surname> <given-names>J.</given-names></name> <name><surname>Ronzano</surname> <given-names>F.</given-names></name> <name><surname>Centeno</surname> <given-names>E.</given-names></name> <name><surname>Sanz</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>The DisGeNET knowledge platform for disease genomics: 2019 update.</article-title> <source><italic>Nucleic Acids Res.</italic></source> <volume>48</volume> <fpage>D845</fpage>&#x2013;<lpage>D855</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz1021</pub-id> <pub-id pub-id-type="pmid">31680165</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polderman</surname> <given-names>J. A.</given-names></name> <name><surname>Farhang-Razi</surname> <given-names>V.</given-names></name> <name><surname>Van Dieren</surname> <given-names>S.</given-names></name> <name><surname>Kranke</surname> <given-names>P.</given-names></name> <name><surname>DeVries</surname> <given-names>J. H.</given-names></name> <name><surname>Hollmann</surname> <given-names>M. W.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Adverse side effects of dexamethasone in surgical patients.</article-title> <source><italic>Cochrane Database Syst. Rev.</italic></source> <volume>11</volume>:<fpage>Cd011940</fpage>.</citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prabhakaran</surname> <given-names>S.</given-names></name> <name><surname>Ruff</surname> <given-names>I.</given-names></name> <name><surname>Bernstein</surname> <given-names>R. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Acute stroke intervention: a systematic review.</article-title> <source><italic>JAMA</italic></source> <volume>313</volume> <fpage>1451</fpage>&#x2013;<lpage>1462</lpage>.</citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname> <given-names>S.</given-names></name> <name><surname>Yang</surname> <given-names>D.</given-names></name> <name><surname>Li</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>W.</given-names></name></person-group> (<year>2021</year>). <article-title>Silencing PAQR3 protects against oxygen-glucose deprivation/reperfusion-induced neuronal apoptosis via activation of PI3K/AKT signaling in PC12 cells.</article-title> <source><italic>Life Sci.</italic></source> <volume>265</volume>:<fpage>118806</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2020.118806</pub-id> <pub-id pub-id-type="pmid">33249098</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname> <given-names>H.</given-names></name> <name><surname>Shen</surname> <given-names>G.</given-names></name> <name><surname>Tang</surname> <given-names>J.</given-names></name> <name><surname>Qiu</surname> <given-names>T.</given-names></name> <name><surname>Zhang</surname> <given-names>Z.</given-names></name> <name><surname>Zhao</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>7</volume>:<fpage>10617</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-10614-5</pub-id> <pub-id pub-id-type="pmid">28878388</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ru</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>P.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Zhou</surname> <given-names>W.</given-names></name> <name><surname>Li</surname> <given-names>B.</given-names></name> <name><surname>Huang</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.</article-title> <source><italic>J. Cheminform.</italic></source> <volume>6</volume>:<fpage>13</fpage>.</citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname> <given-names>P.</given-names></name> <name><surname>Markiel</surname> <given-names>A.</given-names></name> <name><surname>Ozier</surname> <given-names>O.</given-names></name> <name><surname>Baliga</surname> <given-names>N. S.</given-names></name> <name><surname>Wang</surname> <given-names>J. T.</given-names></name> <name><surname>Ramage</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks.</article-title> <source><italic>Genome Res.</italic></source> <volume>13</volume> <fpage>2498</fpage>&#x2013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id> <pub-id pub-id-type="pmid">14597658</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>X.</given-names></name> <name><surname>Yu</surname> <given-names>W.</given-names></name> <name><surname>Liu</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Panax notoginseng saponins administration modulates pro- /anti-inflammatory factor expression and improves neurologic outcome following permanent MCAO in rats.</article-title> <source><italic>Metab. Brain Dis.</italic></source> <volume>32</volume> <fpage>221</fpage>&#x2013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-016-9901-3</pub-id> <pub-id pub-id-type="pmid">27585466</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Hu</surname> <given-names>L.</given-names></name> <name><surname>Yan</surname> <given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>K-3-Rh protects against cerebral ischemia/reperfusion injury by anti-apoptotic effect through PI3K-Akt signaling pathway in rat.</article-title> <source><italic>Neuropsychiatr. Dis. Treat.</italic></source> <volume>16</volume> <fpage>1217</fpage>&#x2013;<lpage>1227</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S233622</pub-id> <pub-id pub-id-type="pmid">32494141</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname> <given-names>D.</given-names></name> <name><surname>Gable</surname> <given-names>A. L.</given-names></name> <name><surname>Lyon</surname> <given-names>D.</given-names></name> <name><surname>Junge</surname> <given-names>A.</given-names></name> <name><surname>Wyder</surname> <given-names>S.</given-names></name> <name><surname>Huerta-Cepas</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.</article-title> <source><italic>Nucleic Acids Res.</italic></source> <volume>47</volume> <fpage>D607</fpage>&#x2013;<lpage>D613</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id> <pub-id pub-id-type="pmid">30476243</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname> <given-names>Z.</given-names></name> <name><surname>Tang</surname> <given-names>C.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name></person-group> (<year>2019</year>). <article-title>Neuroprotective effect of ginkgetin in experimental cerebral ischemia/reperfusion via apoptosis inhibition and PI3K/Akt/mTOR signaling pathway activation.</article-title> <source><italic>J. Cell Biochem.</italic></source> <volume>120</volume> <fpage>18487</fpage>&#x2013;<lpage>18495</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.29169</pub-id> <pub-id pub-id-type="pmid">31265179</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Veleta</surname> <given-names>K. A.</given-names></name> <name><surname>Cleveland</surname> <given-names>A. H.</given-names></name> <name><surname>Babcock</surname> <given-names>B. R.</given-names></name> <name><surname>He</surname> <given-names>Y. W.</given-names></name> <name><surname>Hwang</surname> <given-names>D.</given-names></name> <name><surname>Sokolsky-Papkov</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Antiapoptotic Bcl-2 family proteins BCL-xL and MCL-1 integrate neural progenitor survival and proliferation during postnatal cerebellar neurogenesis</article-title>. <source><italic>Cell Death Differ.</italic></source> <volume>28</volume>, <fpage>1579</fpage>&#x2013;<lpage>1592</lpage>. <pub-id pub-id-type="doi">10.1038/s41418-020-00687-7</pub-id> <pub-id pub-id-type="pmid">33293647</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>Chen</surname> <given-names>H.</given-names></name> <name><surname>Ma</surname> <given-names>S. T.</given-names></name> <name><surname>Mao</surname> <given-names>B. B.</given-names></name> <name><surname>Chen</surname> <given-names>Y.</given-names></name> <name><surname>Xu</surname> <given-names>H. N.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>A network pharmacology approach for exploring the mechanisms of panax notoginseng saponins in ischaemic stroke.</article-title> <source><italic>Evid. Based Complement Alternat. Med.</italic></source> <volume>2021</volume>:<fpage>5582782</fpage>. <pub-id pub-id-type="doi">10.1155/2021/5582782</pub-id> <pub-id pub-id-type="pmid">34434246</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Zhou</surname> <given-names>X. M.</given-names></name> <name><surname>Wu</surname> <given-names>L. Y.</given-names></name> <name><surname>Liu</surname> <given-names>G. J.</given-names></name> <name><surname>Xu</surname> <given-names>W. D.</given-names></name> <name><surname>Zhang</surname> <given-names>X. S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Aucubin alleviates oxidative stress and inflammation via Nrf2-mediated signaling activity in experimental traumatic brain injury.</article-title> <source><italic>J. Neuroinflammation</italic></source> <volume>17</volume>:<fpage>188</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-020-01863-9</pub-id> <pub-id pub-id-type="pmid">32539839</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Shen</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database.</article-title> <source><italic>Nucleic Acids Res.</italic></source> <volume>45</volume> <fpage>W356</fpage>&#x2013;<lpage>W360</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx374</pub-id> <pub-id pub-id-type="pmid">28472422</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y. Y.</given-names></name> <name><surname>Chang</surname> <given-names>C. Y.</given-names></name> <name><surname>Lin</surname> <given-names>S. Y.</given-names></name> <name><surname>Wang</surname> <given-names>J. D.</given-names></name> <name><surname>Wu</surname> <given-names>C. C.</given-names></name> <name><surname>Chen</surname> <given-names>W. Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Quercetin protects against cerebral ischemia/reperfusion and oxygen glucose deprivation/reoxygenation neurotoxicity.</article-title> <source><italic>J. Nutr. Biochem.</italic></source> <volume>83</volume>:<fpage>108436</fpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2020.108436</pub-id> <pub-id pub-id-type="pmid">32599520</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wattanathorn</surname> <given-names>J.</given-names></name> <name><surname>Palachai</surname> <given-names>N.</given-names></name> <name><surname>Thukham-Mee</surname> <given-names>W.</given-names></name> <name><surname>Muchimapura</surname> <given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Memory-enhancing effect of a phytosome containing the combined extract of mulberry fruit and ginger in an animal model of ischemic stroke with metabolic syndrome.</article-title> <source><italic>Oxid. Med. Cell Longev.</italic></source> <volume>2020</volume>:<fpage>3096826</fpage>. <pub-id pub-id-type="doi">10.1155/2020/3096826</pub-id> <pub-id pub-id-type="pmid">32802263</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>L.</given-names></name> <name><surname>Fan</surname> <given-names>Y.</given-names></name> <name><surname>Wei</surname> <given-names>L.</given-names></name> <name><surname>He</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>J.</given-names></name> <name><surname>Zheng</surname> <given-names>X.</given-names></name></person-group> (<year>2020</year>). <article-title>Ablation of TMEM126B protects against oxygen-glucose deprivation/reoxygenation-induced injuries of PC12 cells via maintaining mitochondrial anti-apoptotic functions.</article-title> <source><italic>Arch. Biochem. Biophys.</italic></source> <volume>696</volume>:<fpage>108634</fpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2020.108634</pub-id> <pub-id pub-id-type="pmid">33075301</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>H. Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Y. Q.</given-names></name> <name><surname>Liu</surname> <given-names>Z. M.</given-names></name> <name><surname>Chen</surname> <given-names>T.</given-names></name> <name><surname>Lv</surname> <given-names>C. Y.</given-names></name> <name><surname>Tang</surname> <given-names>S. H.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>ETCM: an encyclopaedia of traditional Chinese medicine.</article-title> <source><italic>Nucleic Acids Res.</italic></source> <volume>47</volume> <fpage>D976</fpage>&#x2013;<lpage>D982</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky987</pub-id> <pub-id pub-id-type="pmid">30365030</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>L.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Yan</surname> <given-names>Z.</given-names></name> <name><surname>Tian</surname> <given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>The role of mTOR signaling pathway on cognitive functions in cerebral ischemia-reperfusion.</article-title> <source><italic>Exp. Ther. Med.</italic></source> <volume>14</volume> <fpage>2839</fpage>&#x2013;<lpage>2844</lpage>.</citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>T.</given-names></name> <name><surname>Guo</surname> <given-names>Q.</given-names></name> <name><surname>Shi</surname> <given-names>X.</given-names></name> <name><surname>Wu</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Panax notoginseng saponins promotes cerebral recovery from ischemic injury by downregulating LINGO-1 and activating the EGFR/PI3K/AKT signaling pathways in vivo.</article-title> <source><italic>J. Tradit. Chin. Med. Sci.</italic></source> <volume>5</volume> <fpage>151</fpage>&#x2013;<lpage>160</lpage>.</citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname> <given-names>H. K.</given-names></name> <name><surname>Dubey</surname> <given-names>N. K.</given-names></name> <name><surname>Lin</surname> <given-names>K. C.</given-names></name> <name><surname>Sung</surname> <given-names>P. H.</given-names></name> <name><surname>Chiang</surname> <given-names>J. Y.</given-names></name> <name><surname>Chu</surname> <given-names>Y. C.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Melatonin rescues cerebral ischemic events through upregulated tunneling nanotube-mediated mitochondrial transfer and downregulated mitochondrial oxidative stress in rat brain.</article-title> <source><italic>Biomed. Pharmacother.</italic></source> <volume>139</volume>:<fpage>111593</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2021.111593</pub-id> <pub-id pub-id-type="pmid">33865018</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>H.</given-names></name> <name><surname>Xiao</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>H. Z.</given-names></name> <name><surname>Zhou</surname> <given-names>J. X.</given-names></name> <name><surname>Ma</surname> <given-names>S. T.</given-names></name> <name><surname>Zhang</surname> <given-names>X. L.</given-names></name></person-group> (<year>2012a</year>). <article-title>Effect of total flavonoids from Dendranthema morifolium (Ramat) Tzvel. cv. Chuju Flowers on Myocardial Ischemia Reperfusion Injury in Rats.</article-title> <source><italic>Food Sci.</italic></source> <volume>33</volume> <fpage>283</fpage>&#x2013;<lpage>286</lpage>.</citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>H.</given-names></name> <name><surname>Zhou</surname> <given-names>G. L.</given-names></name> <name><surname>Liu</surname> <given-names>H. Z.</given-names></name> <name><surname>Zhou</surname> <given-names>J. X.</given-names></name> <name><surname>Yang</surname> <given-names>J. T.</given-names></name></person-group> (<year>2012b</year>). <article-title>Study on the effect of chuju total flavonoids on actue myocardial ischemia in rats.</article-title> <source><italic>Sci. Technol. Food Industr.</italic></source> <volume>33</volume> <fpage>352</fpage>&#x2013;<lpage>354</lpage>.</citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>X. L.</given-names></name> <name><surname>Xiong</surname> <given-names>Y. Y.</given-names></name> <name><surname>Ma</surname> <given-names>S. T.</given-names></name></person-group> (<year>2014</year>). <article-title>Effects of Chuju total flavonoids and panax notoginseng flavonoids on blood glucose and hemorheology in diabetic rats with blood stasis syndrome.</article-title> <source><italic>Chin. Traditional Patent Med.</italic></source> <volume>36</volume> <fpage>830</fpage>&#x2013;<lpage>834</lpage>.</citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>B. B.</given-names></name></person-group> (<year>2013</year>). <source><italic>Analgesic and Anti-Inflammatory Effects of Total Flavonoids of Chuzhou Chrysanth and Its Mechanism.</italic></source> <publisher-loc>Hefei</publisher-loc>: <publisher-name>Anhui Medical University</publisher-name>.</citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>G.</given-names></name> <name><surname>Kim</surname> <given-names>S.</given-names></name> <name><surname>Gu</surname> <given-names>X.</given-names></name> <name><surname>Yu</surname> <given-names>S. P.</given-names></name> <name><surname>Wei</surname> <given-names>L.</given-names></name></person-group> (<year>2020</year>). <article-title>DPP-4 inhibitor linagliptin is neuroprotective in hyperglycemic mice with stroke via the AKT/mTOR pathway and anti-apoptotic Effects.</article-title> <source><italic>Neurosci. Bull.</italic></source> <volume>36</volume> <fpage>407</fpage>&#x2013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-019-00446-w</pub-id> <pub-id pub-id-type="pmid">31808042</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Song</surname> <given-names>Y.</given-names></name> <name><surname>Feng</surname> <given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>Improvement of cerebral ischemia/reperfusion injury by daucosterol palmitate-induced neuronal apoptosis inhibition via PI3K/Akt/mTOR signaling pathway.</article-title> <source><italic>Metab. Brain Dis.</italic></source> <volume>35</volume> <fpage>1035</fpage>&#x2013;<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-020-00575-6</pub-id> <pub-id pub-id-type="pmid">32363473</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K.</given-names></name> <name><surname>Tu</surname> <given-names>M.</given-names></name> <name><surname>Gao</surname> <given-names>W.</given-names></name> <name><surname>Cai</surname> <given-names>X.</given-names></name> <name><surname>Song</surname> <given-names>F.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Hollow prussian blue nanozymes drive neuroprotection against ischemic stroke via attenuating oxidative stress, counteracting inflammation, and suppressing cell apoptosis.</article-title> <source><italic>Nano Lett.</italic></source> <volume>19</volume> <fpage>2812</fpage>&#x2013;<lpage>2823</lpage>. <pub-id pub-id-type="doi">10.1021/acs.nanolett.8b04729</pub-id> <pub-id pub-id-type="pmid">30908916</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Gui</surname> <given-names>S.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Zeng</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Chen</surname> <given-names>Q.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Colon tissue-accumulating mesoporous carbon nanoparticles loaded with Musca domestica cecropin for ulcerative colitis therapy.</article-title> <source><italic>Theranostics</italic></source> <volume>11</volume> <fpage>3417</fpage>&#x2013;<lpage>3438</lpage>. <pub-id pub-id-type="doi">10.7150/thno.53105</pub-id> <pub-id pub-id-type="pmid">33537095</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>T.</given-names></name> <name><surname>Tian</surname> <given-names>C.</given-names></name> <name><surname>Wu</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Kong</surname> <given-names>Q.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>MicroRNA-182 exacerbates blood-brain barrier (BBB) disruption by downregulating the mTOR/FOXO1 pathway in cerebral ischemia.</article-title> <source><italic>FASEB J.</italic></source> <volume>34</volume> <fpage>13762</fpage>&#x2013;<lpage>13775</lpage>. <pub-id pub-id-type="doi">10.1096/fj.201903092R</pub-id> <pub-id pub-id-type="pmid">32808351</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>X. H.</given-names></name> <name><surname>Zhou</surname> <given-names>C. C.</given-names></name> <name><surname>Li</surname> <given-names>C. Y.</given-names></name> <name><surname>Hua</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>K.</given-names></name> <name><surname>Wei</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Isoliquiritin exert protective effect on telencephalon infarction injury by regulating multi-pathways in zebrafish model of ischemic stroke.</article-title> <source><italic>Phytomedicine</italic></source> <volume>83</volume>:<fpage>153469</fpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2021.153469</pub-id> <pub-id pub-id-type="pmid">33535128</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>T.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Feng</surname> <given-names>Y.</given-names></name> <name><surname>Sun</surname> <given-names>G.</given-names></name> <name><surname>Sun</surname> <given-names>X.</given-names></name></person-group> (<year>2021</year>). <article-title>Classical active ingredients and extracts of chinese herbal medicines: pharmacokinetics, pharmacodynamics, and molecular mechanisms for ischemic stroke.</article-title> <source><italic>Oxid. Med. Cell Longev.</italic></source> <volume>2021</volume>:<fpage>8868941</fpage>. <pub-id pub-id-type="doi">10.1155/2021/8868941</pub-id> <pub-id pub-id-type="pmid">33791075</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn id="footnote1">
<label>1</label>
<p><ext-link ext-link-type="uri" xlink:href="http://tcmspw.com/tcmsp.php">http://tcmspw.com/tcmsp.php</ext-link></p></fn>
<fn id="footnote2">
<label>2</label>
<p><ext-link ext-link-type="uri" xlink:href="http://www.tcmip.cn/">http://www.tcmip.cn/</ext-link></p></fn>
<fn id="footnote3">
<label>3</label>
<p><ext-link ext-link-type="uri" xlink:href="http://bionet.ncpsb.org.cn/batman-tcm/">http://bionet.ncpsb.org.cn/batman-tcm/</ext-link></p></fn>
<fn id="footnote4">
<label>4</label>
<p><ext-link ext-link-type="uri" xlink:href="http://www.lilab-ecust.cn/pharmmapper/">http://www.lilab-ecust.cn/pharmmapper/</ext-link></p></fn>
<fn id="footnote5">
<label>5</label>
<p><ext-link ext-link-type="uri" xlink:href="https://www.genecards.org/">https:/www.genecards.org/</ext-link></p></fn>
<fn id="footnote6">
<label>6</label>
<p><ext-link ext-link-type="uri" xlink:href="https://www.omim.org/">https://www.omim.org/</ext-link></p></fn>
<fn id="footnote7">
<label>7</label>
<p><ext-link ext-link-type="uri" xlink:href="https://www.disgenet.org/">https://www.disgenet.org/</ext-link></p></fn>
<fn id="footnote8">
<label>8</label>
<p><ext-link ext-link-type="uri" xlink:href="https://string-db.org/">https://string-db.org/</ext-link></p></fn>
<fn id="footnote9">
<label>9</label>
<p><ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/">https://david.ncifcrf.gov/</ext-link></p></fn>
</fn-group>
</back>
</article>